Who owns Aspire Biopharma Holdings Inc?
- CUSIP Number: 738920206
Tip: Access positions for across all investors
Analyze quarterly positions in Aspire Biopharma Holdings with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aspire Biopharma Holdings stock
Who bought or sold Aspire Biopharma Holdings Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| UBS Group | 192k | $197k | 100% | Mar 2026 |
|
| Morgan Stanley | 77k | $79k | 100% | Mar 2026 |
|
| Geode Capital Management | 43k | $45k | 100% | Mar 2026 |
|
| Crewe Advisors | 20k | $21k | 100% | Mar 2026 |
|
| Vanguard Capital Management | 7.9k | $8.1k | 100% | Mar 2026 |
|
| Toronto-Dominion Bank | 5.0k | $5.2k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 2.9k | $2.9k | 100% | Mar 2026 |
|
| Citigroup | 1.8k | $1.9k | 100% | Mar 2026 |
|
| Efficient Wealth Management | 1.4k | $999.939200 | 100% | Mar 2026 |
|
| SBI Securities | 1.00 | $1.000000 | 100% | Mar 2026 |
|
| Caitong International Asset Management | 1.00 | $1.000000 | 100% | Mar 2026 |
|